Literature DB >> 28710674

What is the best predictor of severe ovarian hyperstimulation syndrome in IVF? A cohort study.

Theoni B Tarlatzi1, Christos A Venetis2, Fabienne Devreker3, Yvon Englert3, Anne Delbaere3.   

Abstract

PURPOSE: The purpose of the present study is to study what is the best predictor of severe ovarian hyperstimulation syndrome (OHSS) in IVF.
METHODS: This is a retrospective analysis of all consecutive IVF/intracytoplasmic injection cycles performed during a 5-year period (2009-2014) in a single university fertility centre. All fresh IVF cycles where ovarian stimulation was performed with gonadotrophins and GnRH agonists or antagonists and triggering of final oocyte maturation was induced with the administration of urinary or recombinant hCG were analyzed (2982 patients undergoing 5493 cycles). Because some patients contributed more than one cycle, the analysis of the data was performed with the use of generalized estimating equation (GEE).
RESULTS: Severe OHSS was diagnosed in 20 cycles (0.36%, 95% CI 0.20-0.52). The number of follicles ≥10 mm on the day of triggering final oocyte maturation represents the best predictor of severe OHSS in IVF cycles. The cutoff in the number of follicles ≥10 mm with the best capacity to discriminate between women that will and will not develop severe OHSS was ≥15.
CONCLUSION: The presence of more than 15 follicles ≥10 mm on the day of triggering final oocyte maturation represents the best predictor of severe OHSS in IVF cycles.

Entities:  

Keywords:  IVF; Number of follicles; OHSS; Prediction; Prevention

Mesh:

Substances:

Year:  2017        PMID: 28710674      PMCID: PMC5633577          DOI: 10.1007/s10815-017-0990-7

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  51 in total

1.  Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization.

Authors:  B C Fauser; D de Jong; F Olivennes; H Wramsby; C Tay; J Itskovitz-Eldor; H G van Hooren
Journal:  J Clin Endocrinol Metab       Date:  2002-02       Impact factor: 5.958

2.  Serum estradiol level and oocyte number in predicting severe ovarian hyperstimulation syndrome.

Authors:  C D Chen; M Y Wu; K H Chao; S U Chen; H N Ho; Y S Yang
Journal:  J Formos Med Assoc       Date:  1997-10       Impact factor: 3.282

3.  LH/FSH ratio as a predictor of ovarian hyperstimulation syndrome.

Authors:  J Bódis; A Török; H R Tinneberg
Journal:  Hum Reprod       Date:  1997-04       Impact factor: 6.918

4.  Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin-releasing hormone antagonist protocol in combination with a "freeze-all" strategy: a prospective multicentric study.

Authors:  Georg Griesinger; Laura Schultz; Thomas Bauer; Anke Broessner; Thorsten Frambach; Stefan Kissler
Journal:  Fertil Steril       Date:  2011-03-02       Impact factor: 7.329

5.  Prorenin and active renin concentrations in plasma and ascites during severe ovarian hyperstimulation syndrome.

Authors:  A Delbaere; P J Bergmann; C Gervy-Decoster; M Camus; V de Maertelaer; Y Englert
Journal:  Hum Reprod       Date:  1997-02       Impact factor: 6.918

6.  Risk factors and prognostic variables in the ovarian hyperstimulation syndrome.

Authors:  D Navot; A Relou; A Birkenfeld; R Rabinowitz; A Brzezinski; E J Margalioth
Journal:  Am J Obstet Gynecol       Date:  1988-07       Impact factor: 8.661

7.  Angiotensin II immunoreactivity is elevated in ascites during severe ovarian hyperstimulation syndrome: implications for pathophysiology and clinical management.

Authors:  A Delbaere; P J Bergmann; C Gervy-Decoster; M Staroukine; Y Englert
Journal:  Fertil Steril       Date:  1994-10       Impact factor: 7.329

8.  Management of severe early ovarian hyperstimulation syndrome by re-initiation of GnRH antagonist.

Authors:  T G Lainas; I A Sfontouris; I Z Zorzovilis; G K Petsas; G T Lainas; E M Kolibianakis
Journal:  Reprod Biomed Online       Date:  2007-10       Impact factor: 3.828

9.  Cumulative conception and live birth rates after the treatment of anovulatory infertility: safety and efficacy of ovulation induction in 200 patients.

Authors:  A H Balen; D D Braat; C West; A Patel; H S Jacobs
Journal:  Hum Reprod       Date:  1994-08       Impact factor: 6.918

Review 10.  Predicting and preventing ovarian hyperstimulation syndrome (OHSS): the need for individualized not standardized treatment.

Authors:  Klaus Fiedler; Diego Ezcurra
Journal:  Reprod Biol Endocrinol       Date:  2012-04-24       Impact factor: 5.211

View more
  4 in total

1.  Inhibin A-A Promising Predictive Parameter for Determination of Final Oocyte Maturation in Ovarian Stimulation for IVF/ICSI.

Authors:  Barbara Lawrenz; Leyla Depret Bixio; Carol Coughlan; Claus Yding Andersen; Laura Melado; Bhanu Kalra; Gopal Savjani; Human M Fatemi; Ajay Kumar
Journal:  Front Endocrinol (Lausanne)       Date:  2020-05-15       Impact factor: 5.555

2.  Nomogram Model to Predict the Probability of Ovarian Hyperstimulation Syndrome in the Treatment of Patients With Polycystic Ovary Syndrome.

Authors:  Fei Li; Ying Chen; Aiqin Niu; Yajing He; Ying Yan
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-06       Impact factor: 5.555

3.  Lipid Analysis of Follicular Fluids by UHPLC-ESI-HRMS Discovers Potential Biomarkers for Ovarian Hyperstimulation Syndrome.

Authors:  Yue Gao; Jingjie Li; Shicheng Fan; Pan Chen; Min Huang; Huichang Bi
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-29       Impact factor: 6.055

4.  GnRH agonist-triggering ovulation in women with advanced age.

Authors:  Einat Haikin Herzberger; Amir Wiser; Roni Rahav Koren; Netanella Miller; Rimon Moran; Dean Decter; Arie Berkowitz
Journal:  Sci Rep       Date:  2022-09-30       Impact factor: 4.996

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.